Latest News and Press Releases

Dublin, March 04, 2025 (GLOBE NEWSWIRE) -- The "Breast Cancer Liquid Biopsy - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...

New York, United States, March 04, 2025 (GLOBE NEWSWIRE) -- Breast cancer is the prevailing ailment in the population, predominantly affecting women who are witnessing an increase in disease...

Myriad Genetics announced a collaboration with Gabbi to provide an integrated offering for breast cancer risk assessment.

New York, USA, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Breast Cancer Market Sees Rapid Growth — Key Insights and Forecasts of Different Breast Cancers for the Coming 10 Years | DelveInsight The breast...

Plus Therapeutics Advances Lead Drug Rhenium (186Re) Obisbemeda for Patients with Leptomeningeal Metastases

– Announced that topline data from the monotherapy Phase 3 VERITAC-2 trial is anticipated in 1Q25 – – Presented Phase 1b data from the TACTIVE-U sub-study of vepdegestrant in...

The new study adds to growing evidence that measuring activated proteins is key to cancer therapy selection. Golden, CO, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Ignite Proteomics LLC, a subsidiary of...

NEWARK, Del, Feb. 07, 2025 (GLOBE NEWSWIRE) -- The global breast reconstruction surgery market is set for remarkable expansion, with market projections indicating a 7.5% CAGR from 2025 to 2035....

University Cancer & Blood Center (UCBC), based in Athens, Georgia, announces that Dr. Ashley Ray now has her certification in oncoplastic breast surgery.

Myriad Genetics and CancerCARE for Life announced an agreement designed to enhance education and access to hereditary cancer testing.